GPT and steatosis: While recent guidelines have emphasized the importance of screening for liver fibrosis in individuals at risk (ie, those with diabetes, with 2 or more cardiometabolic risk factors, or with elevated alanine aminotransferase/aspartate aminotransferase or evidence of steatosis), implementation of these recommendations in clinics has been rather slow [35].